Vermedx Receives $500,000 Series A Financing

  • Feed Type
  • Date
    5/1/2009
  • Company Name
    Vermedx
  • Mailing Address
    371 Pearl St Burlington, VT 05401
  • Company Description
    The American health care system is poorly equipped to effectively and cost-efficiently manage chronic disease in general, and diabetes in particular. With 40 million Americans affected by diabetes and related costs exceeding $100 billion annually, established treatment practices are simply not good enough.Vermedx programs embody the Chronic Care Model (CCM). This widely embraced approach to improving health outcomes emphasizes enabling provider teams to be prepared and proactive, and to interact regularly and effectively with well informed patients. It directly counteracts a leading factor in the current problem set: clinical inertia.
  • Website
    http://www.vermedx.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    FreshTracks Capital, a venture firm based in Shelburne, VT, led the financing, which is intended to provide Vermedx with funds to enhance marketing efforts and continue to develop products.
  • M&A Terms
  • Venture Investor
    Fresh Tracks Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.